3Patnaik A K,Ehler W J,MacEwen E G.Canine Cutaneous Mast.Cell Tumor Morphologic Grading and Survival Time in 83 Dogs[J]. Veterinary Pathology, 1984,21:469-474.
4Pohlman L M.Basophils mast cells and their disorders.In:Weiss DJ Wardrop K J Schalm’s veterinary hematology[M].6th edition Iowa:Wiley-Blackwell,2010:290-297.
5Blackwood L,Murphy S,Buracco P,et al.European consensusdocument on mast cell tumours in dogs and cats[J].Veterinary andComparative Oncology,2012(10):1-29.
6Baker-Gabb M,Hunt G B,France M P.Soft tissue sarcomas andmast cell tumours in dogs;clinical behaviour and response to surgery[J].Australian Veterinary Journal 2003,81:732-780.
7Seguin B,Leinman N F,Bregazzi V S,et al.Clinical outcome ofdogs with grade-II mast cell tumours treated with surgery alone:55 cases(1996-1999)[J].Journal of the American VeterinaryMedical Association,2001,218:1120-1123.
8Simpson A M,Ludwig L L,Newman S J,et al.Evaluation of surgical margins required for complete excision of cutaneous mastcell tumours in dogs[J].Journal of the American Veterinary Medical Association,2004,224:236-240.
9Fulcher R P,Ludwig L L,Bergman P J,et al.Evaluation of atwo-centimeter lateral surgical margin for excision of grade I andgrade II cutaneous mast cell tumours in dogs[J].Journal of theAmerican Veterinary Medical Association,2006,228:210-215.
10London C A,Malpas P B,Wood-Follis S L,et al.Multi-center,placebo-controlled,double-blind,randomized study of oral toceranib phosphate(SU11654),a receptor tyrosine kinase inhibitor,forthe treatment of dogs with recurrent(either local or distant)mastcell tumour following surgical excision[J].Clinical Cancer Research,2009,15:3856-3865.
二级参考文献10
1Hendrick M J,Mahaffey E A,Moore F M,et al.HistologicalClassification of Mesenchymal Tumors of Skin and Soft Tis-sues of Domestic Animals[M].Washington DC:ArmedForces Institute of Pathology,1998:64.
2Goldschmidt M H,Dunstan R W,Stannard A A,et al.His-tological Classification of Epithelial and Melanocytic Tumors ofthe Skin of Domestic Animals[M].Washington,DC:ArmedForces Institute of Pathology,1998:106.
3Withrow S G.Small Animal Clinical Oncology[M].4th ed.Saunders Elsevier,2007:375-401.
4Dobson J M,Samuel S,Milstein H,et al.Canine neoplasia inthe UK estimates of incidence rates from a population of in-sured dogs[J].Journal of Small Animal Practice,2002,43:240-246.
5Schmidt J M,North S M,Freeman K P,et al.Canine paedia-tric oncology retrospective assesment of 9522tumors in dogsup to 12months(1993-2008)[J].Veterinary and ComparativeOncology,2010,8:283-292.
7Ghisleni G,Roccabianca P,Ceruti R,et al.Correlation be-tween fine-needle aspiration cytology and histopathology in theevaluation of cutaneous and subcutaneous masses from dogsand cats[J].Veterinary Clinical Pathology,2006,35:24-30.
8Patnaik A K,Ehler W J,MacEwen E G.Canine CutaneousMast Cell Tumor Morphologic Grading and Survival Time in83Dogs[J].Veterinary Pathology,1984,21:469-474.
